Montréal, Canada

Aurélien Colamartino

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aurélien Colamartino: Innovator in Synthetic Expression Cassettes

Introduction

Aurélien Colamartino is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of biotechnology, particularly in the development of synthetic expression cassettes. His work focuses on enhancing the expression of nucleic acids in specific cell types, which has important implications for medical treatments.

Latest Patents

Colamartino holds a patent for "Cell specific transcriptional regulatory sequences and uses thereof." This patent discloses new synthetic expression cassettes that comprise a minimal promoter and a cell-specific enhancer. These innovations allow for the expression of a nucleic acid of interest in one or more specific cell subtypes. The patent also includes vectors and host cells that utilize these synthetic expression cassettes. Furthermore, it outlines methods for expressing nucleic acids, such as those encoding chimeric antigen receptors (CAR), and for treating diseases like cancers and genetic disorders.

Career Highlights

Colamartino is associated with Valorisation Hsj, Limited Partnership, where he continues to advance his research and development efforts. His work is pivotal in the biotechnology sector, particularly in creating tools that can lead to more effective treatments for various diseases.

Collaborations

Colamartino collaborates with talented individuals such as Élie Haddad and Panojot Bifsha. These partnerships enhance the innovative capacity of his projects and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Aurélien Colamartino is a key figure in the field of synthetic biology, with a focus on developing innovative solutions for medical applications. His contributions through patents and collaborations are paving the way for future advancements in the treatment of complex diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…